United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Soligenix announces promising results in extended HyBryte treatment study for cutaneous T-cell lymphoma Soligenix, Inc. (Nasdaq: SNGX), a late-stage biopharmaceutical company, has shared an interim update on a key study involving… byPallavi MadhirajuJuly 10, 2024